Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02490397 · ClinicalTrials.gov registry record · NA
Impact of Daylight on Patients With Acute Myocardial Infarction
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02490397: Clinical Trial NA study, sponsored by University of Colorado, Denver.
NCT02490397 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02490397, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The study tests if intense light could be a potential therapy in humans after myocardial infarction by inducing Per2.
Primary Outcome
Measure of Per2 protein levels related to daylight exposure vs. room light exposure after 2 weeks.
Interventions
- OTHER Day Light
- OTHER Room Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-07 |
| Est. Completion | 2020-12-28 |
| Phase | NA |
Why NCT02490397 stopped before completion
NCT02490397 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Day Light is the first listed.
NCT02490397 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02490397 about?
NCT02490397 is a clinical study titled "Impact of Daylight on Patients With Acute Myocardial Infarction". The study tests if intense light could be a potential therapy in humans after myocardial infarction by inducing Per2.
What is the current status of trial NCT02490397?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2015-07. Estimated completion is 2020-12-28.
What interventions are being tested in trial NCT02490397?
The interventions under investigation include: Day Light (OTHER), Room Light (OTHER).
Who is sponsoring clinical trial NCT02490397?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02490397's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia